Medicare billing address
CMS Medicare provider billing file
2315 Myrtle StreetSuite 190
Erie, PA 16502
CMS public data · NPI 1376521062
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Andrew L Mecca, MD
Specialty
Credential
MD
NPI
1376521062
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Andrew L Mecca, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2315 Myrtle StreetCMS Doctors & Clinicians file
2315 Myrtle StIn the 2024 CMS provider billing file, this NPI had 2,624 Medicare beneficiaries and 6,286 total services. The average beneficiary age was 76, and the average HCC risk score was 1.7.
Total Medicare allowed amount
$200,478.14
Total Medicare payment amount
$152,159.76
Medicare beneficiaries
2,624
Total services
6,286
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
46%
CMS beneficiary-panel share
Heart failure
41%
CMS beneficiary-panel share
Atrial fibrillation
40%
CMS beneficiary-panel share
Diabetes
35%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 3,644 | $7.90 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 659 | $28.57 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 384 | $86.25 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 295 | $35.50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 262 | $13.73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 207 | $7.90 |
| Programming of dual lead pacemaker system | 165 | $35.61 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 69 | $76.78 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 64 | $168.84 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 62 | $115.48 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1376521062. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Metoprolol Succinate | Metoprolol Succinate | 416 | 1,137.5 | $8,461.43 |
| 2 | Eliquis | Apixaban | 401 | 866.2 | $493,781.50 |
| 3 | Amiodarone Hcl | Amiodarone Hcl | 309 | 837.7 | $6,553.30 |
| 4 | Xarelto | Rivaroxaban | 129 | 273 | $147,592.84 |
| 5 | Diltiazem 24Hr Er (Cd) | Diltiazem Hcl | 112 | 309.7 | $3,149.22 |
| 6 | Flecainide Acetate | Flecainide Acetate | 104 | 306 | $4,362.02 |
| 7 | Dofetilide | Dofetilide | 95 | 243.9 | $35,835.46 |
| 8 | Digoxin | Digoxin | 83 | 225.5 | $1,328.59 |
| 9 | Metoprolol Tartrate | Metoprolol Tartrate | 59 | 169.5 | $633.89 |
| 10 | Sotalol | Sotalol Hcl | 59 | 155.9 | $1,498.88 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
R Franklin University Of Med & Sci/Chicago Medical School
Graduation year
1988
Group/practice field
Saint Vincent Consultants In Cardiovascular Diseases
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Cardiovascular Disease (Cardiology).
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.